Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility Of Hemoglobin A1C (HbA1C) For The Diagnosis Of Gestational Diabetes Mellitus (GDM).

NCT02273193 is registered in ClinicalTrials.gov with Mike O'Callaghan Military Hospital as lead sponsor.

NCT NCT02273193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02273193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility Of Hemoglobin A1C (HbA1C) For The Diagnosis Of Gestational Diabetes Mellitus (GDM).
Lead sponsor
Mike O'Callaghan Military Hospital
Phase
Observational
Overall status
Completed
Start date
October 14, 2014
Completion date
July 1, 2017
Enrollment
643 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes mellitus